Back
Global X S&P Catholic Values Developed ex-US ETF Vs. Jazz Pharmaceuticals Plc Industry Stock Comparison
Buy
52
CEFA
Global X S&P Catholic Values Developed ex-US ETF
Last Price:
$37.55
Seasonality Move:
0.71%
Buy
63
JAZZ
Jazz Pharmaceuticals Plc
Last Price:
$186.87
Seasonality Move:
15.66%
Buy
52
Global X S&P Catholic Values Developed ex-US ETF (CEFA)
is a Buy
Is Global X S&P Catholic Values Developed ex-US ETF a Buy, Sell or Hold?
-
The current Global X S&P Catholic Values Developed ex-US ETF [CEFA] share price is $37.27. The Score for CEFA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CEFA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Jazz Pharmaceuticals Plc (JAZZ)
is a Buy
Is Jazz Pharmaceuticals Plc a Buy, Sell or Hold?
-
The current Jazz Pharmaceuticals Plc [JAZZ] share price is $186.95. The Score for JAZZ is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
JAZZ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CEFA Stock Price Chart
What is Global X S&P Catholic Values Developed ex-US ETF's stock price today?
-
The Global X S&P Catholic Values Developed ex-US ETF share price today is $37.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CEFA is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAZZ Stock Price Chart
What is Jazz Pharmaceuticals Plc's stock price today?
-
The Jazz Pharmaceuticals Plc share price today is $186.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JAZZ is experiencing slight buying pressure.
CEFA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.21 | Buy |
| Relative Strength Index (14 RSI): | 49.28 | Sell |
| Chaikin Money Flow: | 1653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.26 - 38.34) | Sell |
| Bollinger Bands (100): | (36.47 - 39.03) | Sell |
JAZZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 56.41 | Buy |
| Chaikin Money Flow: | 99997 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (181.31 - 188.21) | Buy |
| Bollinger Bands (100): | (159.39 - 183.63) | Buy |
CEFA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.61 | Buy |
| 20-day SMA: | 36.92 | Buy |
| 50-day SMA: | 38.4 | Sell |
| 200-day SMA: | 36.53 | Buy |
| 8-day EMA: | 36.14 | Buy |
| 20-day EMA: | 29.31 | Buy |
| 50-day EMA: | 17.35 | Buy |
| 200-day EMA: | 5.43 | Buy |
JAZZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 186.67 | Buy |
| 20-day SMA: | 183.98 | Buy |
| 50-day SMA: | 177.12 | Buy |
| 200-day SMA: | 147.45 | Buy |
| 8-day EMA: | 186.19 | Buy |
| 20-day EMA: | 184.12 | Buy |
| 50-day EMA: | 178.58 | Buy |
| 200-day EMA: | 155.1 | Buy |
Global X S&P Catholic Values Developed ex-US ETF Earnings Growth & CEFA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Jazz Pharmaceuticals Plc Earnings Growth & JAZZ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $1.59 per share, an increase this year of $15.74 per share, and an increase next year of $1.01 per share.
Global X S&P Catholic Values Developed ex-US ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Jazz Pharmaceuticals Plc Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||